IDYA
IDEAYA Biosciences, Inc. · Healthcare · Biotechnology
Momentum inputs (comparable managers):
holder breadth -7.1% ·
share flow -2.9% ·
net new positions -7.7%
— formula
Broad distribution — falling shares and fewer holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q1 2025
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 100 | +4 | 68.09M | $2.53B | +10 | −5 |
| Q1 2026 | 98 | +2 | 72.39M | $2.41B | +9 | −8 |
| Q4 2025 | 96 | 0 | 74.31M | $2.57B | +1 | — |
| Q3 2025 | 17 | -1 | 45.06M | $1.23B | — | −2 |
| Q2 2025 | 16 | 0 | 43.75M | $919.60M | +1 | −1 |
| Q1 2025 | 13 | -1 | 14.55M | $238.33M | +1 | −2 |
| Q4 2024 | 14 | +1 | 14.99M | $385.22M | +1 | — |
| Q3 2024 | 12 | -1 | 10.73M | $339.97M | — | −1 |
| Q2 2024 | 13 | — | 11.98M | $420.72M | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | T. Rowe Price ✦ | 3.48M | -10.1% | $56.93M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 2 | T. Rowe Price ✦ | 3.48M | -10.1% | $56.93M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 3 | State Street Global Advisors ✦ (passive) | 3.45M | +3.8% | $56.45M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 4 | Geode Capital Management ✦ (passive) | 2.08M | +4.6% | $34.08M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 5 | Geode Capital Management ✦ (passive) | 2.08M | +4.6% | $34.08M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 6 | Citadel Advisors ✦ | 1.51M | -18.1% | $24.65M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 7 | Citadel Advisors ✦ | 1.51M | -18.1% | $24.65M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 8 | Adage Capital Partners ✦ | 1.19M | -1.0% | $19.46M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 9 | Fisher Asset Management ✦ | 965.03K | +10.1% | $15.81M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 10 | Millennium Management ✦ | 547.64K | +345.2% | $8.97M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 11 | Two Sigma Investments ✦ | 468.58K | +10.6% | $7.68M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 12 | Renaissance Technologies ✦ | 357.60K | +25.8% | $5.86M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 13 | D. E. Shaw & Co. ✦ | 308.56K | +70.8% | $5.05M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 14 | Point72 Asset Management ✦ | 140.12K | New | $2.30M | 0.0% | New | 1 | SEC ↗ |
| 15 | Wellington Management ✦ | 36.49K | -8.3% | $597,641 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 16 | Wellington Management ✦ | 36.49K | -8.3% | $597,641 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 17 | Wellington Management ✦ | 36.49K | -8.3% | $597,641 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 18 | Wellington Management ✦ | 36.49K | -8.3% | $597,641 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 19 | Norges Bank ✦ (passive) | 30.59K | -94.1% | $501,048 | 0.0% | ▼ Trim | 2 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| Point72 Asset Management | $2.30M | 0.0% |
Exited
| Marshall Wace | $8.04M | was 0.0% |
| AQR Capital Management | $353,709 | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 253 holders, 94.40M shares, $3.10B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.